MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/wjo2.183

Медицинская библиотека · World journal of otorhinolaryngology - head and neck surgery · 2024

Effect of drug therapies on self-reported chemosensory outcomes after COVID-19.

Fornazieri Marco A, Cunha Bruno M, Nicácio Samuel P, Anzolin Lucas K, da Silva José L B, Neto Aristides Fernandes, Neto Deusdedit Brandão, Voegels Richard L, Pinna Fábio D R

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

The aim of this study was to assess the relative efficacy of medications used following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection on self-reported alterations in taste and/or smell function.

METHODS

Seven hundred and fourteen persons with self-reported postcoronavirus disease 2019 (post-COVID-19) chemosensory disorders were personally interviewed regarding specific medications they were administered following the acute phase of the disease. The dependent measure-self-reported total recovery of chemosensory symptoms-was subjected to stepwise logistic regression. Independent predictors included demographic and clinical variables, in addition to specific medications used to mitigate disease symptoms (i.e., systemic corticosteroids, oseltamivir, vitamin C, ibuprofen, hydroxychloroquine, azithromycin, ivermectin, nitazoxanide, anticoagulants, and zinc).

RESULTS

The median time between COVID-19 symptom onset and the interviews was 81 days (interquartile range: 60-104). Of the 714 subjects, 249 (34.9%) reported total recovery of their chemosensory function; 437 (61.2%) had at least one treatment since the beginning of the disease. Women and those with more comorbidities had undergone more treatments. The recovery rates of the treated and nontreated groups did not differ significantly. Nonetheless, respondents who had used nitazoxanide tended to have a higher rate of self-reported taste or smell recovery. Those who took oral zinc were less likely to improve.

CONCLUSIONS

No medication employed during the first months after SARS-CoV-2 infection had a clear positive effect on returning self-reported smell or taste function to normal, although nitrazoxide trended in a positive direction. Oral zinc had a negative effect on the reported recovery of these senses.

Для цитирования: Fornazieri Marco A, Cunha Bruno M, Nicácio Samuel P, Anzolin Lucas K, da Silva José L B, Neto Aristides Fernandes, Neto Deusdedit Brandão, Voegels Richard L, Pinna Fábio D R. Effect of drug therapies on self-reported chemosensory outcomes after COVID-19.. World journal of otorhinolaryngology - head and neck surgery. 2024. DOI: 10.1002/wjo2.183.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.